8th Annual Cancer Survivorship Conference: Clinical Management of Immunotherapy Sequelae
To provide health care professionals with the knowledge and skills needed o promote evidence-based care to oncology patients and their families throughout the survivorship continuum.
Virtual attendance of oncology and non-oncology providers including physicians, advanced practice providers, nurses, social workers, and other healthcare providers working with patients and families surviving cancer across the nation.
Upon completion of this program, attendees will:
• Have increased knowledge of health promotion, assessment, and needs management strategies in survivorship.
• Identify local, regional, and national health promotion resources that are available for healthcare providers and survivors.
• Have increased knowledge of methods to promote adherence throughout all phases of survivorship.
Agenda 7:30 am
Microsoft Teams Log In/Industry Breakout
G. van Londen, MD, MSc
Saša Živković, MD, PhD Neurologic Complications of Cancer Immunotherapy
Rowena Schwartz, PharmD, BCOP Keynote - Considerations in Toxicity Management with Immunotherapy: Beyond the Common Toxicities from Trials to Patient Care Issues
Timothy Patton, DO Cutaneous Side Effects of Immune/Targeted Cancer Therapies
Diana Pinkhasova, MD Immunotherapy-Related Endocrinopathies
Elad Sharon, MD, MPH Keynote
Closing G. van Londen, MD, MSc
Microsoft Teams Log Off
G. van Londen, MD, MSc
Director, Cancer LiveWell Survivorship Program
UPMC Hillman Cancer Center and Magee-Womens Cancer Program
Catherine M. Bender, PhD, RN, FAAN
Professor, Nursing and Clinical and Translational Science Institute
Nancy Glunt Hoffman Endowed Chair in Oncology Nursing
University of Pittsburgh School of Nursing
Co-Leader, Biobehavioral Cancer Control Program
Jill A. Brufsky, PharmD
Adjunct Assistant Professor of Medicine, University of Pittsburgh
Kathleen Bryte, MSN, RN, OCN
Clinical Education Specialist
Patient, Family, and Community Education Nurse
UPMC Hillman Cancer Center at UPMC Passavant
Kayla Bylinowski, PA-C
Oncology Hematology Associates
UPMC Hillman Cancer Center at Butler Health System
All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
The following relevant financial relationships were disclosed:
• Rowena Schwartz, PharmD, BCOP, Consultant: Merck-Biosimilars
• Saša Živković, MD, PhD, Grant/Research Support: Alnylam Pharmaceuticals and Pfizer, Consultant: Alnylam Pharmaceuticals, Argenx, and CSL Behring.
No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Pittsburgh designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.5 contact hours.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
As a Jointly Accredited Organization, University of Pittsburgh is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. University of Pittsburgh maintains responsibility for this course. Social workers completing this course receive 4.5 continuing education credits.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 4.50 AAPA Category I CME
- 4.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 4.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 4.50 ASWB
- 4.50 Attendance
We gratefully acknowledge support from the following exhibitors for this activity:
• Amgen – Hematology
• Astra Zeneca
• Bristol Myers Squibb
• MorphoSys US Inc
• Sanofi Genzyme/Regeneron - Libtayo
All cancellations must be emailed to Brittni Prosdocimo at email@example.com by Friday, October 30, 2020. Tuition for cancellations will be refunded in full if received by Friday, October 30, 2020. If cancellation received after Friday, October 30, 2020, no refund will be issued.
For more information, contact Brittni Prosdocimo at firstname.lastname@example.org or 412-623-3671.